Form 4 for PCVX Vaxcyte, Inc.
Accepted 2021-09-23 00:00:00 ET · period of report 2021-09-21 · accession 0001209191-21-057469 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-09-23 | 2021-09-21+ | PCVX | PICKERING GRANT | CEO, Dir | M - OptEx | $1.79 | +15.0K | 584.4K | +3% | +$26.9K |
| DM | 2021-09-23 | 2021-09-21+ | PCVX | PICKERING GRANT | CEO, Dir | S - Sale+OE | $25.21 | -15.0K | 580.3K | -3% | -$378.2K |
| DM | 2021-09-23 | 2021-09-21+ | PCVX | PICKERING GRANT | CEO, Dir | M - OptEx | $0.00 | -15.0K | 363.0K | -4% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-09-21 | M | A | 10,807 | $1.79 | 591,061 | D | — | — | |
| 2 | Common | Common Stock | 2021-09-21 | S | D | 10,005 | $25.17 | 581,056 | D | — | — | (F2) The price reported is a weighted-average price. The shares were sold at prices ranging from $24.73 to $25.59. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 3 | Common | Common Stock | 2021-09-21 | S | D | 802 | $25.89 | 580,254 | D | — | — | (F3) The price reported is a weighted-average price. The shares were sold at prices ranging from $25.88 to $25.94. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 4 | Common | Common Stock | 2021-09-22 | M | A | 4,193 | $1.79 | 584,447 | D | — | — | |
| 5 | Common | Common Stock | 2021-09-22 | S | D | 4,193 | $25.19 | 580,254 | D | — | — | (F4) The price reported is a weighted-average price. The shares were sold at prices ranging from $24.90 to $25.45. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 6 | Derivative | Stock Option (right to buy) | 2021-09-22 | M | D | 4,193 | $0.00 | 358,815 | D | $1.79 · — to 2027-05-17 | 4,193 Common Stock | (F5) The shares subject to the option are fully vested and exercisable. |
| 7 | Derivative | Stock Option (right to buy) | 2021-09-21 | M | D | 10,807 | $0.00 | 363,008 | D | $1.79 · — to 2027-05-17 | 10,807 Common Stock | (F5) The shares subject to the option are fully vested and exercisable. |